Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluad vs Fluzone HD in Long Term Care Residents
NCT03694808Phase 4Completed
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Fluzone Trivalent in influenza (2 arms). Primary endpoints: Overall Hemagglutinin Inhibition (HAI) H1N1 Titer at 1 month, Overall Hemagglutinin Inhibition (HAI) H3N2 Titer at 1 month and 4 more. Started Sep 2018; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03694808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694808.